You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窝轮》【瑞通认股证牛熊证】大市续反弹 恒指、科指好仓受捧 中芯受惠消息 即市资金追好仓
阿思达克 03-12 11:11
美国总统拜登签署1.9万亿美元的纾困法案,道指隔晚续创新高,收报32485点,升188点(或0.58%)。恒指昨收报29385点,升478点(或1.65%),一举收复10天及50天线,并连升三日。今早再升逾100点,重上29500点。恒指好仓(牛证及认购权证)昨净流出近1.5亿港元(下同),恒指淡仓(熊证及认沽权证)同日净流入逾1亿元,反映投资者预期恒指将见调整。昨日恒指牛证街货重货区为收回价27800至27899点,而熊证街货重货区为收回价30000至30099点。

中美两国半导体行业协会宣布共同成立「中美半导体产业技术和贸易限制工作组」加强交流。中芯(00981)昨曾飙逾12%至27.25元,全日急弹一成收市,报26.7元,终止五日跌势,并一举收复10天、20天和50天线。中芯今早好淡争持,曾升抵27元。昨分别有逾660万元和逾10万元净流出其轮证好仓和淡仓。

石药(01093)继周三公布签订肿瘤产品授权商业化协议後,昨与康诺亚生物订立协议,以总代价1.7亿人民币取得中重度哮喘和慢性阻塞性肺病等呼吸系统疾病产品之独家开发权及商业化,获券商唱好,刺激石药股价昨一度炒起12.5%,见9.8元近五个月高,收市维持10.9%升幅,报9.66元。股份连续两日抽升,累涨逾16%。今早略回,失守9.6元。石药将於下周一公布去年业绩。昨有逾750万元净流出其好仓,淡仓同日则有逾70万元净流入。

据报内地反垄断监管机构拟考虑对阿里巴巴(09988)处以破纪录罚款。另有传阿里巴巴正在整合内部资源组成社区团购业务事业群。此外,有传中证监拟最快下月提高於上海科创板首次上市公司的要求,市场认为将增加蚂蚁集团日後的上市难度。阿里近日受制下移中的10天线阻力,昨逆市微跌0.35%收市,报227.6元,230元关得而复失。阿里今早曾回升逾2%,重返230元以上。昨分别录近1700万元以及逾140万元净流入其好仓和淡仓。

美国成品油库存大幅减少,加上经合组织调升全球经济增长预测,市场对经济前景感乐观,支持国际油价上升。中石化(00386)昨收升1.17%於4.34元,结束两连跌并重越10天线。股份自上月中旬一直沿着20天线向上,今早升约1%,上试4.4元,暂於10天和20天线以下徘徊。近90万元在昨日净流入其好仓,淡仓同日则有小量资金净流出。

瑞通相关认股证之选择:

恒指轻微价外、中年期购22836,行使价:32000点,2021年10月到期,实际杠杆:9倍

恒指轻微价外、中短期沽18412,行使价:27600点,2021年8月到期,实际杠杆:7.2倍

恒科贴价、中短期购28327,行使价:9000元,2021年6月到期,实际杠杆:5.8倍

恒科轻微价外、短期沽18584,行使价:7600元,2021年5月到期,实际杠杆:5.5倍

中芯价外、中年期购22834,行使价:35.88元,2021年9月到期,实际杠杆:2.9倍

石药轻微价外、中年期购12495,行使价:10.9元,2021年9月到期,实际杠杆:4.2倍

阿里轻微价外、中短期购29646,行使价:253.888元,2021年7月到期,实际杠杆:6.1倍

阿里轻微价外、中短期沽27517,行使价:212.88元,2021年7月到期,实际杠杆:5.1倍

中化轻微价外、中年期购12723,行使价:5.09元,2021年10月到期,实际杠杆:5.2倍

瑞通相关牛熊证之选择:

恒指牛证53783,收回价:28860点,杠杆比率:46.7倍

恒指熊证56706,收回价:30090点,杠杆比率:31.3倍

恒科牛证57294,收回价:7500元,杠杆比率:5.6倍

恒科熊证61535,收回价:9690元,杠杆比率:8.4倍

中芯牛证60123,收回价:21.88元,杠杆比率:3.8倍

中芯熊证52848,收回价:29.6元,杠杆比率:6.3倍

石药熊证53093,收回价:10元,杠杆比率:8.6倍

阿里牛证61895,收回价:215.88元,杠杆比率:11.3倍

阿里熊证50080,收回价:245.88元,杠杆比率:11.3倍~

重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account